Two scientist in a lab, QIAsymphony, interacting, Handbook, Guidance

Infectious Disease

Get high diagnostic accuracy with digital PCR for infectious disease detection and control

Why choose digital PCR for molecular diagnostics?

Digital PCR (dPCR) is a powerful tool for clinical testing and diagnostics of infectious diseases due to its high precision and sensitivity in nucleic acid detection. Unlike traditional PCR methods, dPCR enables the absolute quantification of target DNA or RNA by partitioning a sample into thousands of individual reactions, each representing a minute volume. This method enhances the detection of low-abundance pathogens and provides accurate quantification even in the presence of inhibitors. Learn more about the advantages:

Learn more about dPCR for clinical testing
Monkeypox resources
Let us help. We are prioritizing efforts to support your lab.
Learn more

Improving care for transplant recipients

Immunocompromised transplant patients are highly susceptible to post-op infections. What can you do when viral load assays don't give you a complete diagnostic picture of your patient's immune response?

QuantiFERON transplant assays provide a complementary approach – helping you assess the risk of infection and guide your patient management.

Learn more
Female surgeon at the operating table

Assays for pathogen detection and viral load monitoring

QIAGEN provides a broad portfolio of diagnostic assays for pathogen detection and viral load monitoring.

Complete validated workflows provide standardized and reliable solutions for routine testing. Automation with the QIAsymphony RGQ integrates automated sample preparation and assay setup with detection on the Rotor-Gene Q MDx to maximize your efficiency and optimize your workflows, from sample to result.

Choose the workflow below for the pathogen of interest.

COVID-19 solutions
Learn more about our comprehensive diagnostic and research portfolio
Learn more

Disclaimers:

QIAcuity Digital PCR instruments are sold under license from Bio-Rad Laboratories, Inc.and exclude rights for use with pediatric applications

QIAcuityDx medical device is currently under development and will be available in 20 countries in H2 2024.